ITI Pharma and Healthcare Fund - Regular Plan - Growth vs HDFC Pharma and Healthcare Fund Regular Plan IDCW Reinvestment
NAV, returns and costs — not a recommendation.
 ITI Pharma and Healthcare Fund - Regular Plan - Growth |  HDFC Pharma and Healthcare Fund Regular Plan IDCW Reinvestment | |
|---|---|---|
| NAV | ₹17.6626 | ₹21.181 |
| NAV date | 2026-09-30 | 2026-09-30 |
| 1 year | +11.85% | +26.37% |
| 3 year (p.a.) | +16.84% | +28.69% |
| 5 year (p.a.) | +12.35% | +28.69% |
| Expense ratio | 2.38% | 1.97% |
| Fund size | ₹276.23 Cr | ₹2362.44 Cr |
| Risk | Very high | — |
| Category | Sectoral Pharma and Healthcare | Sectoral Pharma and Healthcare |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.